Page last updated: 2024-08-25

zoledronic acid and Insulin Resistance

zoledronic acid has been researched along with Insulin Resistance in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giagourta, I; Karga, H; Kassi, G; Ktena, V; Papaioannou, G; Papamichael, K; Papandroulaki, F; Thanou, S; Triantaphyllopoulou, M; Zapanti, E1
Anastasilakis, AD; Bisbinas, I; Delaroudis, S; Gerou, S; Gkiomisi, A; Makras, P; Papadopoulou, E; Polyzos, SA; Sakellariou, GT1

Other Studies

2 other study(ies) available for zoledronic acid and Insulin Resistance

ArticleYear
Cytokines and insulin resistance after zoledronic acid-induced acute phase response.
    Immunological investigations, 2014, Volume: 43, Issue:6

    Topics: Acute-Phase Reaction; Adiponectin; Bone Density Conservation Agents; C-Reactive Protein; Diphosphonates; Female; Humans; Hydrocortisone; Imidazoles; Insulin Resistance; Interleukin-6; Leptin; Middle Aged; Osteoporosis, Postmenopausal; Resistin; Tumor Necrosis Factor-alpha; Zoledronic Acid

2014
The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.
    Clinical endocrinology, 2012, Volume: 77, Issue:6

    Topics: Acute-Phase Reaction; Adipokines; Age Factors; Aged; Bone Density; Bone Density Conservation Agents; Cytokines; Diphosphonates; Female; Humans; Imidazoles; Insulin Resistance; Lymphocyte Count; Middle Aged; Nicotinamide Phosphoribosyltransferase; Osteoporosis, Postmenopausal; Postmenopause; Risk Factors; Zoledronic Acid

2012